Effect of low dose vitamin D on serum inflammatory factors in maintenance hemodialysis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0001017

Enrollment

Registered

2014-03-07

Start date

2014-03-03

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : The vitamin D (Cholecalciferol) is going to be supplied by oral, 3,000 IU per time, 3 times/week, for 6 months.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Maintenance Hemodialysis patient Serum 25(OH)D < 30 ng/ml Vintage of Maintenance Hemodialysis over 3 months

Exclusion criteria

Exclusion criteria: Patient who is on active vitamin D sterol(calcio, bonky, zemplar) Patient who is on Cinacalcet Liver cirrhosis Acute or Chronic infection patient (Pneumonia, Diabetic foot etc, any acute infection 1 month before participating the study or more than 3 months of chronc infection) Anti-inflammatory medication or steroid (1 month before the study) Hypercalcemia (>10.6mg/dl) history of Urinary stone Malignancy Intact PTH over 800 pg/ml Chronic inflammotry disease or auto-immune disease On immunosupressant drugs History of kidney transplantation History of Parathyroidectomy Impossible to participate the study determined by the investigator

Design outcomes

Primary

Measure	Time frame
25(OH)D;1,25(OH)D	—

Countries

Korea, Republic of

Contacts

Public ContactHyun-jung Ko

Hanyang University Guri Hospital

Outcome results